{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:28:14Z","timestamp":1782170894305,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Skabies stellt weltweit eine der h\u00e4ufigsten und hinsichtlich der Krankheitslast bedeutendsten Hautkrankheiten dar. In Deutschland wird derzeit eine Zunahme von F\u00e4llen diskutiert, wof\u00fcr bisher belastbare Zahlen fehlten.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Fragestellung<\/jats:title>\n                <jats:p>H\u00e4ufigkeit und Versorgungsmerkmale der Skabies in Deutschland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methode<\/jats:title>\n                <jats:p>Multi-Source-Analysen aus Versorgungsdaten einer bundesweiten gesetzlichen Krankenversicherung, des Statistischen Bundesamtes und von betrieblichen Hautscreenings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>In Deutschland weist Skabies seit 2009 und insbesondere seit 2014 eine steigende Versorgungspr\u00e4valenz auf. Im ambulanten Bereich findet sich ein Anstieg zwischen 2010 und 2015 von 52,8\u202f% auf etwa 128.000 Behandlungsf\u00e4lle. Station\u00e4r werden in Deutschland derzeit j\u00e4hrlich \u00fcber 11.000 F\u00e4lle mit Skabies als Hauptdiagnose (ICD-10 B86) dokumentiert. Der Anstieg zwischen 2010 und 2016 betrug etwa 306\u202f%. Hauptversorgende ambulante Fachgruppen sind Dermatologen und Haus\u00e4rzte, im station\u00e4ren Bereich Fachabteilungen f\u00fcr Dermatologie, P\u00e4diatrie und Innere Medizin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Der Versorgungsbedarf wird zuk\u00fcnftig aufgrund der vorgenannten Entwicklung von Pr\u00e4valenz und Inzidenz weiter auf einem hohen Niveau bleiben, was einen erh\u00f6hten Aufkl\u00e4rungs- und Fr\u00fcherkennungsbedarf nahelegt.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00105-021-04895-1","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T02:20:44Z","timestamp":1633400444000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiologie der Skabies in Deutschland: Multi-Source-Analyse von Prim\u00e4r- und Sekund\u00e4rdaten","Epidemiology of scabies in Germany: multisource analysis of primary and secondary data"],"prefix":"10.1007","volume":"73","author":[{"given":"Matthias","family":"Augustin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefion","family":"Girbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Str\u00f6mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"issue":"4","key":"4895_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1365-2133.2011.10436.x","volume":"165","author":"M Augustin","year":"2011","unstructured":"Augustin\u00a0M, Herberger\u00a0K, Hintzen\u00a0S, Heigel\u00a0H, Franzke\u00a0N, Schaefer\u00a0I (2011) Prevalence of skin lesions and need for treatment in a\u00a0cohort of 90880 workers. Br J Dermatol 165(4):865\u2013873","journal-title":"Br J Dermatol"},{"key":"4895_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S1473-3099(19)30068-4","volume":"19","author":"O Chosidow","year":"2019","unstructured":"Chosidow\u00a0O, Hay\u00a0RJ (2019) Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings. Lancet Infect Dis 19:454\u2013456","journal-title":"Lancet Infect Dis"},{"key":"4895_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMct0910329","volume":"362","author":"BJ Currie","year":"2010","unstructured":"Currie\u00a0BJ, McCarthy\u00a0JS (2010) Permethrin and ivermectin for scabies. N\u00a0Engl J Med 362:717\u2013725","journal-title":"N Engl J Med"},{"key":"4895_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(19)31136-5","volume":"394","author":"D Engelman","year":"2019","unstructured":"Engelman\u00a0D, Cantey\u00a0PT, Marks\u00a0M et\u00a0al (2019) The public health control of scabies: priorities for research and action. Lancet 394:81\u201392","journal-title":"Lancet"},{"key":"4895_CR5","doi-asserted-by":"publisher","first-page":"e2167","DOI":"10.1371\/journal.pntd.0002167","volume":"7","author":"D Engelman","year":"2013","unstructured":"Engelman\u00a0D, Kiang\u00a0K, Chosidow\u00a0O et\u00a0al (2013) Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis 7:e2167","journal-title":"PLoS Negl Trop Dis"},{"key":"4895_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-4632.2011.04953.x","volume":"50","author":"RJ Hay","year":"2011","unstructured":"Hay\u00a0RJ, Fuller\u00a0LC (2011) Assessment of dermatological needs in resource-poor regions. Int J Dermatol 50:552\u2013557","journal-title":"Int J Dermatol"},{"key":"4895_CR7","unstructured":"DIMDI (2019) Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification (ICD-10-GM) Vorabfassung 2020. https:\/\/www.dimdi.de\/static\/de\/klassi\/icd-10-gm\/index.htm. Zugegriffen: 4. Sept. 2019"},{"key":"4895_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","volume":"17","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani\u00a0C, Colombara\u00a0DV, Drucker\u00a0AM et al (2017) The global burden of scabies: a\u00a0cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis 17:1247\u20131254","journal-title":"Lancet Infect Dis"},{"key":"4895_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1155\/2011\/698494","volume":"22","author":"V Leung","year":"2011","unstructured":"Leung\u00a0V, Miller\u00a0M (2011) Detection of scabies: a\u00a0systematic review of diagnostic methods. Can J Infect Dis Med Microbiol 22:143\u2013146","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4895_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","volume":"15","author":"L Romani","year":"2015","unstructured":"Romani\u00a0L, Steer\u00a0AC, Whitfeld\u00a0MJ, Kaldor\u00a0JM (2015) Prevalence of scabies and impetigo worldwide: a\u00a0systematic review. Lancet Infect Dis 15:960\u2013967","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"4895_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdv.12102","volume":"28","author":"IA Schaefer","year":"2014","unstructured":"Schaefer\u00a0IA, Spehr\u00a0C, Reusch\u00a0M, Kornek\u00a0T (2014) Prevalence and risk factors of actinic keratoses in Germany\u2014analysis of multisource data. J\u00a0Eur Acad Dermatol Venereol 28(3):309\u2013313","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4895_CR12","unstructured":"Statistisches Bundesamt (2017) Diagnosedaten der Patienten und Patientinnen in Krankenh\u00e4usern (einschl. Sterbe- und Stundenf\u00e4lle). https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Krankenhaeuser\/Publikationen\/Downloads-Krankenhaeuser\/diagnosedaten-krankenhaus-2120621167004.pdf?__blob=publicationFile. Zugegriffen: 29. Apr. 2020"},{"key":"4895_CR13","first-page":"15","volume":"17","author":"C Sunderk\u00f6tter","year":"2019","unstructured":"Sunderk\u00f6tter\u00a0C, Aebischer\u00a0A, Neufeld\u00a0M et\u00a0al (2019) Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J\u00a0Dtsch Dermatol Ges 17:15\u201323","journal-title":"J Dtsch Dermatol Ges"},{"key":"4895_CR14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/ddg.13130","volume":"14","author":"C Sunderk\u00f6tter","year":"2016","unstructured":"Sunderk\u00f6tter\u00a0C, Feldmeier\u00a0H, F\u00f6lster-Holst\u00a0R et al (2016) S1 guidelines on the diagnosis and treatment of scabies\u2014short version. J\u00a0Dtsch Dermatol Ges 14:1155\u20131167","journal-title":"J Dtsch Dermatol Ges"},{"key":"4895_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archdermatol.2011.51","volume":"147","author":"B Walter","year":"2011","unstructured":"Walter\u00a0B, Heukelbach\u00a0J, Fengler\u00a0G et al (2011) Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a\u00a0resource-poor setting. Arch Dermatol 147:468\u2013473","journal-title":"Arch Dermatol"},{"key":"4895_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-4632.2011.05017.x","volume":"51","author":"C Worth","year":"2012","unstructured":"Worth\u00a0C, Heukelbach\u00a0J, Fengler\u00a0G et\u00a0al (2012) Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol 51:275\u2013282","journal-title":"Int J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04895-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T09:06:26Z","timestamp":1641978386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04895-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04895-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"assertion":[{"value":"1 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Augustin, C.\u00a0Garbe, G.\u00a0Girbig, K.\u00a0Str\u00f6mer und N.\u00a0Kirsten geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}